Pharma TechSep 25, 2026
China expands its manufacturing role for biopharma’s new drugs
Biopharma firms are increasingly choosing to manufacture their newer FDA-approved innovator and biosimilar products at facilities in China.
Read MorePharmaVoice Blog
Premium industry intelligence for pharma media leaders
PharmaShotsSep 25, 2026
Top 20 Oncology Companies of 2026Â
Shots: 20. Eisai Oncology Segment Revenue: $2.26B Founded Year: 1941 Market Cap: $9.14B Total Employees: 10,500 Headquarters: Tokyo, Japan Stock Exchange: TYO 19. Merck KGaA Oncology Segment Revenue: $2.41B Founded Year: 1668 Market Cap: $19.87B Total Employees: 62,100 Headquarters: Darmstadt, Germany Stock Exchange: ETR 18. GSK Oncology Segment Revenue: $2.68B Founded Year: 2000 Market Cap: $134.44B … The post Top 20 Oncology Companies of 2026 appeared first on PharmaShots.
Read More
Pharma TechSep 25, 2026
FDA commissioner nominee affirms MMR vaccine safety despite Trump’s claims
Despite Dr Heidi Overton’s declaration, senators questioned whether the commissioner-elect would challenge erroneous statements from president Trump.
Read More
Pharma TechSep 25, 2026
Roche and Earendil forge $1.5bn bispecific discovery deal
Roche joins Sanofi on the list of big pharma companies that are betting on Earendil’s AI-powered drug discovery platform.
Read More
Pharma TechSep 25, 2026
Amberstone and Henlius agree to develop solid-tumour T-cell engagers
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Read MoreSponsored Content
Brand stories and partner placements
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer